Log hier in om volledige toegang te krijgen. Lees meer over Podcast: EGFR ex20ins gemuteerd NSCLC in de dagelijkse klinische praktijk - Jan von der Thüsen ...

Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...

The CheckMate -816 trial shows nivolumab plus platinum-doublet chemotherapy significantly improves overall survival in ...

The study enrolled 64 patients with treatment-naïve metastatic melanoma between March 2017 and July 2019. Participants ...

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

David Zhen, MD, discussed the relevance of nivolumab in the upper gastrointestinal cancer population. In an interview with ...

An expert discusses how CheckMate 274 is a phase 3, randomized, double-blind trial evaluating adjuvant nivolumab vs placebo in patients with high-risk muscle-invasive urothelial carcinoma (MIUC) after ...

Patients with advanced RCC who were treated with nivolumab plus cabozantinib had a median PFS of 16.4 months compared with 8.3 months from sunitinib alone. Nivolumab (Opdivo) plus cabozantinib ...

In patients with advanced melanoma, nivolumab/relatlimab combination therapy shows a cutaneous irAEs prevalence of 21.5%, ...

Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...